<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03557645</url>
  </required_header>
  <id_info>
    <org_study_id>VHI Hemodynamics</org_study_id>
    <nct_id>NCT03557645</nct_id>
  </id_info>
  <brief_title>Ventilator Hyperinflation and Hemodynamics</brief_title>
  <acronym>VHI-HD</acronym>
  <official_title>Hemodynamic Repercussions of Ventilator Hyperinflation Using Volume-controlled Ventilation: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Universitário Augusto Motta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidade Federal do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centro Universitário Augusto Motta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventilator hyperinflation (VHI) has been shown to be effective in improving respiratory
      mechanics, secretion removal, and gas exchange in mechanically ventilated patients; however,
      the literature is scarce concerning its safety and adverse effects. Thus, the aim of this
      study is to compare the hemodynamic repercussions of VHI in volume-controlled mode. In a
      randomized, controlled and crossover design, 24 mechanically ventilated patients will undergo
      2 modes of ventilator hyperinflation (with and without an inspiratory pause) and a control
      intervention. Cardiac output, cardiac index, mean arterial pressure, pulmonary vascular
      resistance, systolic volume and other hemodynamic variables will be recorded during the
      interventions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: ventilator hyperinflation (VHI) has been shown to be effective in improving
      respiratory mechanics, secretion removal, and gas exchange in mechanically ventilated
      patients; however, the literature is scarce concerning its safety and adverse effects. Thus,
      the aim of this study is to compare the hemodynamic repercussions of VHI in volume-controlled
      mode.

      Methods: in a randomized, controlled and crossover design, 24 mechanically ventilated
      patients will undergo 2 modes of ventilator hyperinflation (with and without an inspiratory
      pause of 2 seconds) and a control intervention. For the VHI interventions, the inspiratory
      flow will be set at 20 Lpm, and tidal volume will be increased until a peak pressure of
      40cmH2O is achieved. During the control intervention, the patients will remain in
      volume-control ventilation with an inspiratory flow = 60Lpm and tidal volume = 6mL/IBW. The
      interval between interventions (washout) will be of 10 minutes or more, according to the time
      needed to recover the cardiac index to baseline values (maximum difference of 10%). Cardiac
      output, cardiac index, mean arterial pressure, pulmonary vascular resistance, systolic volume
      and other hemodynamic variables will be recorded during the interventions by using impedance
      cardiography.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">June 4, 2018</start_date>
  <completion_date type="Anticipated">July 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Crossover Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cardiac Output</measure>
    <time_frame>Baseline (before) and 10 minutes after the onset of VHI modesBasel</time_frame>
    <description>Estimation of cardiac output variation using thoracic bioimpedance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Cardiac Index</measure>
    <time_frame>Baseline (before) and 10 minutes after the onset of VHI modes</time_frame>
    <description>Estimation of cardiac index variation using thoracic bioimpedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Vascular pulmonary resistance</measure>
    <time_frame>Baseline (before) and 10 minutes after the onset of VHI modes</time_frame>
    <description>Estimation of vascular pulmonary resistance variation using thoracic bioimpedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Systolic Volume</measure>
    <time_frame>Baseline (before) and 10 minutes after the onset of VHI modes</time_frame>
    <description>Estimation of systolic volume variation using thoracic bioimpedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Mean Arterial Pressure</measure>
    <time_frame>Baseline (before) and 10 minutes after the onset of VHI modes</time_frame>
    <description>Recording of mean arterial pressure variation using an automatic noninvasive device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cardiac Output II</measure>
    <time_frame>Baseline (before) and 5 minutes after the end of VHI modes</time_frame>
    <description>Estimation of cardiac output variation using thoracic bioimpedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cardiac Index II</measure>
    <time_frame>Baseline (before) and 5 minutes after the end of VHI modes</time_frame>
    <description>Estimation of cardiac index variation using thoracic bioimpedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Vascular pulmonary resistance II</measure>
    <time_frame>Baseline (before) and 5 minutes after the end of VHI modes</time_frame>
    <description>Estimation of vascular pulmonary resistance variation using thoracic bioimpedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Systolic Volume II</measure>
    <time_frame>Baseline (before) and 5 minutes after the end of VHI modes</time_frame>
    <description>Estimation of systolic volume variation using thoracic bioimpedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Mean Arterial Pressure II</measure>
    <time_frame>Baseline (before) and 5 minutes after the end of VHI modes</time_frame>
    <description>Recording of mean arterial pressure variation using an automatic noninvasive device</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Respiratory Failure</condition>
  <condition>Respiratory Disorders</condition>
  <arm_group>
    <arm_group_label>Baseline Mechanical Ventilation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The subjects will be kept in Volume Control Continuous Mandatory Ventilation (VC-CMV) with an inspiratory flow = 60Lpm and tidal volume = 6mL/IBW. Positive end-expiratory pressure and the inspired oxygen fraction will not be modified.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VHI With Inspiratory Pause</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV). The inspiratory flow will be set at 20Lpm, the tidal volume will be increased in steps of 200mL until the peak airway pressure of 40cmH2O is achieved, and an inspiratory pause will be applied at the end of inspiration. After achieving the target pressure, this ventilatory regimen will last 15 minutes. Positive end-expiratory pressure and the inspired oxygen fraction will not be modified.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VHI Without Inspiratory Pause</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV). The inspiratory flow will be set at 20Lpm and the tidal volume will be increased in steps of 200mL until the peak airway pressure of 40cmH2O is achieved. After achieving the target pressure, this ventilatory regimen will last 15 minutes. Positive end-expiratory pressure and the inspired oxygen fraction will not be modified.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Baseline Mechanical Ventilation</intervention_name>
    <description>The subjects will be kept in Volume Control Continuous Mandatory Ventilation (VC-CMV).</description>
    <arm_group_label>Baseline Mechanical Ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VHI With Inspiratory Pause</intervention_name>
    <description>Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV) with an inspiratory pause.</description>
    <arm_group_label>VHI With Inspiratory Pause</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VHI Without Inspiratory Pause</intervention_name>
    <description>Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV) without an inspiratory pause.</description>
    <arm_group_label>VHI Without Inspiratory Pause</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients under mechanical ventilation for more than 48h

        Exclusion Criteria:

          -  mucus hypersecretion (defined as the need for suctioning &lt; 2-h intervals),

          -  absence of respiratory drive,

          -  atelectasis,

          -  severe bronchospasm,

          -  positive end expiratory pressure &gt; 10cmH2O,

          -  PaO2-FiO2 relationship &lt; 150,

          -  mean arterial pressure &lt; 60mmHg,

          -  inotrope requirement equivalent to &gt;15 ml/h total of adrenaline and noradrenalin,

          -  intracranial pressure &gt; 20mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando Guimaraes, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Centro Universitário Augusto Motta</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fernando Guimaraes, PhD</last_name>
    <phone>+5521991243760</phone>
    <email>fguimaraes_pg@yahoo.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Santa Martha</name>
      <address>
        <city>Niterói</city>
        <state>Rio De Janeiro</state>
        <zip>24241-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <contact>
      <last_name>Sérgio Chermont, PhD</last_name>
      <phone>+5521997759909</phone>
      <email>schermont@yahoo.com.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>https://www.researchgate.net/profile/FERNANDO_GUIMARAES</url>
    <description>Main researcher - personal profile in Researchgate</description>
  </link>
  <results_reference>
    <citation>Berney S, Denehy L. A comparison of the effects of manual and ventilator hyperinflation on static lung compliance and sputum production in intubated and ventilated intensive care patients. Physiother Res Int. 2002;7(2):100-8.</citation>
    <PMID>12109234</PMID>
  </results_reference>
  <results_reference>
    <citation>Lemes DA, Zin WA, Guimaraes FS. Hyperinflation using pressure support ventilation improves secretion clearance and respiratory mechanics in ventilated patients with pulmonary infection: a randomised crossover trial. Aust J Physiother. 2009;55(4):249-54.</citation>
    <PMID>19929767</PMID>
  </results_reference>
  <results_reference>
    <citation>Anderson A, Alexanders J, Sinani C, Hayes S, Fogarty M. Effects of ventilator vs manual hyperinflation in adults receiving mechanical ventilation: a systematic review of randomised clinical trials. Physiotherapy. 2015 Jun;101(2):103-10. doi: 10.1016/j.physio.2014.07.006. Epub 2014 Oct 6. Review.</citation>
    <PMID>25453540</PMID>
  </results_reference>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 13, 2018</study_first_submitted>
  <study_first_submitted_qc>June 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2018</study_first_posted>
  <last_update_submitted>June 4, 2018</last_update_submitted>
  <last_update_submitted_qc>June 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mechanical ventilation</keyword>
  <keyword>physiotherapy</keyword>
  <keyword>ventilator hyperinflation</keyword>
  <keyword>airway clearance technique</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

